Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014

Ann J. Melvin(University of Washington), Kathryn P. Gray(Dana-Farber Cancer Institute), Elizabeth J. McFarland(University of Colorado Anschutz Medical Campus), Hedy Teppler(Unknown), Mounika Yedla(Frontier Science & Technology Research Foundation, Inc.), Supattra Rungmaitree(Siriraj Hospital), Nicole H. Tobin(National Institutes of Health), Hassena Cassim(University of the Witwatersrand), Chelsea Krotje(Frontier Science & Technology Research Foundation, Inc.), Rachel Scheckter(Family Health International 360), Katie McCarthy(Family Health International 360), Havilland Campbell(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jack Moye(National Institutes of Health), Pradthana Ounchanum(ChiangRai Prachanukroh Hospital), Hong Wan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Brookie M. Best, Linda Aurpibul(Chiang Mai University), Ka Lai Yee(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ellen Cooper(Boston University), Patricia M. Flynn(St. Jude Children's Research Hospital), Ellen Townley(National Institutes of Health)
JAIDS Journal of Acquired Immune Deficiency Syndromes
October 10, 2022
Cited by 3


Related Papers